Agenda
1:30 PM — 5:00 PM
Risk Management Plans and Drug Utilization Studies in Canada7:00 AM — 8:10 AM
8:15 AM — 8:30 AM
Welcome and Opening Remarks10:00 AM — 10:30 AM
12:00 PM — 1:30 PM
1:30 PM — 3:00 PM
Session 3 - Track A: Communications with Regulators and Among Industry1:30 PM — 3:00 PM
Session 3 - Track B: Vendor Management1:30 PM — 3:00 PM
Session 3 - Track C: Patient Access3:00 PM — 3:30 PM
3:30 PM — 5:00 PM
Session 4 - Track A: Unique Regulatory Requirements in Canada3:30 PM — 5:00 PM
Session 4 - Track B: Inspectorate Town Hall – GVP Inspections3:30 PM — 5:00 PM
Session 4 - Track C: Communication to Patients and Public/Consumer7:30 AM — 8:30 AM
8:30 AM — 10:00 AM
Session 5 - Track A: Transforming Drug Safety and Surveillance8:30 AM — 10:00 AM
Session 5 - Track C: Health Technology Assessments10:00 AM — 10:30 AM
10:30 AM — 12:00 PM
Session 6 - Track A: Subsequent Entry Biologics/Biosimilars10:30 AM — 12:00 PM
Session 6 - Track B: Biostatistics12:00 PM — 1:30 PM
Have an account?